Tudor Investment Corp ET AL Makes New $4.17 Million Investment in Phreesia, Inc. $PHR

Tudor Investment Corp ET AL acquired a new stake in shares of Phreesia, Inc. (NYSE:PHR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 177,409 shares of the company’s stock, valued at approximately $4,173,000. Tudor Investment Corp ET AL owned 0.30% of Phreesia at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Federated Hermes Inc. purchased a new position in Phreesia during the 3rd quarter valued at about $32,000. Asset Management One Co. Ltd. bought a new stake in Phreesia during the third quarter worth about $45,000. State of Alaska Department of Revenue purchased a new stake in Phreesia in the third quarter worth about $83,000. Anchor Investment Management LLC purchased a new stake in Phreesia in the third quarter worth about $118,000. Finally, Tower Research Capital LLC TRC increased its stake in shares of Phreesia by 332.5% during the second quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company’s stock valued at $160,000 after purchasing an additional 4,313 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Insider Buying and Selling

In other Phreesia news, SVP Amy Beth Vanduyn sold 2,602 shares of Phreesia stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $44,260.02. Following the completion of the sale, the senior vice president owned 160,238 shares of the company’s stock, valued at approximately $2,725,648.38. This trade represents a 1.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Balaji Gandhi sold 8,009 shares of Phreesia stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total value of $136,233.09. Following the completion of the sale, the chief financial officer directly owned 156,231 shares of the company’s stock, valued at approximately $2,657,489.31. The trade was a 4.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 66,529 shares of company stock worth $1,080,454 over the last 90 days. 5.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

PHR has been the subject of several recent research reports. Canaccord Genuity Group lowered their target price on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, December 9th. Wall Street Zen downgraded Phreesia from a “strong-buy” rating to a “buy” rating in a research note on Sunday, February 8th. Truist Financial set a $24.00 price objective on Phreesia in a research report on Thursday, January 8th. Robert W. Baird lowered their price objective on Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, December 10th. Finally, JPMorgan Chase & Co. dropped their target price on Phreesia from $29.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, February 20th. Seventeen equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $28.94.

Phreesia Stock Down 0.3%

Shares of Phreesia stock opened at $11.24 on Thursday. The company has a 50-day simple moving average of $12.81 and a two-hundred day simple moving average of $18.05. The stock has a market capitalization of $677.84 million, a PE ratio of -112.42 and a beta of 0.67. Phreesia, Inc. has a 52-week low of $10.75 and a 52-week high of $32.76. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.